Venomyx Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Venomyx Therapeutics General Information

Description

Developer of novel antitoxin therapeutics designed to make snakebite treatment safe, effective, and affordable. The company's therapeutics include antivenom that covers a broad spectrum of snakebites and low immunogenicity, apart from being portable and manufactured at scale using microbial fermentation, it enables patients to get cured of snakebites without any side effects.

Contact Information

Website
www.venomyx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 11011 North Torrey Pines Road
  • Suite 135
  • La Jolla, CA 92037
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 11011 North Torrey Pines Road
  • Suite 135
  • La Jolla, CA 92037
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Venomyx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 28-May-2024 Completed Out of Business
6. Seed Round Completed Generating Revenue
5. Grant 15-Sep-2021 Completed Generating Revenue
4. Seed Round 01-Jul-2021 Completed Generating Revenue
3. Equity Crowdfunding 03-Jul-2019 Completed Generating Revenue
2. Seed Round 01-May-2019 $250K Completed Generating Revenue
1. Accelerator/Incubator 07-Oct-2016 $250K $250K Completed Generating Revenue
To view Venomyx Therapeutics’s complete valuation and funding history, request access »

Venomyx Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Venomyx Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11028159-B2 Composition and methods for treating snake envenomation Inactive 02-May-2017
US-20200157197-A1 Composition and methods for treating snake envenomation Active 02-May-2017
WO-2018204153-A1 Composition and methods for treating snake envenomation Inactive 02-May-2017 C07K16/18

Venomyx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Venomyx Therapeutics FAQs

  • When was Venomyx Therapeutics founded?

    Venomyx Therapeutics was founded in 2015.

  • Where is Venomyx Therapeutics headquartered?

    Venomyx Therapeutics is headquartered in La Jolla, CA.

  • What is the size of Venomyx Therapeutics?

    Venomyx Therapeutics has 3 total employees.

  • What industry is Venomyx Therapeutics in?

    Venomyx Therapeutics’s primary industry is Drug Discovery.

  • Is Venomyx Therapeutics a private or public company?

    Venomyx Therapeutics is a Private company.

  • What is Venomyx Therapeutics’s current revenue?

    The current revenue for Venomyx Therapeutics is .

  • How much funding has Venomyx Therapeutics raised over time?

    Venomyx Therapeutics has raised $818K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process